GlaxoSmithKline Consumer Healthcare
BSE: 500676 | NSE: GSKCONS | ISIN: INE264A01014 | Food Processing
 |
Half Yearly Results of GlaxoSmithKline Consumer Healthcare |
------------------- in Rs. Cr. ------------------- |
| Jun '07 | Dec '07 | Jun '08 | Dec '08 | Jun '09 | ||||||
| ||||||||||
|
||||||||||
| 6 mths | 6 mths | 6 mths | 6 mths | 6 mths | ||||||
|
||||||||||
| Sales Turnover | 642.10 | 635.70 | 786.93 | 805.37 | 1,041.12 | |||||
| Other Income | 30.50 | 38.40 | 44.75 | 1.21 | 14.29 | |||||
| Total Income | 672.60 | 674.10 | 831.68 | 806.58 | 1,055.41 | |||||
| Total Expenses | 523.50 | 533.70 | 652.68 | 652.58 | 813.68 | |||||
| Operating Profit | 118.60 | 102.00 | 134.25 | 152.79 | 227.44 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 149.10 | 140.40 | 179.00 | 154.00 | 241.73 | |||||
| Interest | 2.20 | 2.40 | 2.54 | 4.43 | 2.37 | |||||
| PBDT | 146.90 | 138.00 | 176.46 | 149.57 | 239.36 | |||||
| Depreciation | 19.30 | 20.50 | 20.85 | 21.10 | 21.14 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 127.60 | 117.50 | 155.61 | 128.47 | 218.22 | |||||
| Tax | 43.00 | 39.50 | 52.89 | 42.86 | 79.14 | |||||
| Net Profit | 84.60 | 78.00 | 102.72 | 85.61 | 139.08 | |||||
| Prior Year Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share(Rs) | 20.10 | 18.53 | 24.42 | 20.35 | 33.07 | |||||
| Book Value(Rs) | -- | -- | -- | -- | -- | |||||
| Equity | 42.10 | 42.10 | 42.06 | 42.06 | 42.06 | |||||
| Reserves | -- | -- | -- | -- | -- | |||||
| Face Value(Rs) | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore GlaxoSmith Con connections | ||||||||||
| ||||||||||
